Zimmer Biomet saw increased growth during the second quarter – but the company also confirmed on its recent Q2 earnings call that its quality remediation efforts continue, with fresh FDA observations arising from the agency's most recent inspection of one of Zimmer's Indiana-based manufacturing facilities.
ZimmerBiomet Holdings Inc. confirmed on a recent earnings call that the company’s US FDA quality systems compliance challenges aren’t over quite yet.
The firm received additional observations after FDA’s most recent inspection of its Warsaw North Campus facility in Warsaw, Ind., President...